- Research works
- 87 ▼ 8% vs 2013–17
- Citations
- 1.6k 18.8 per fractional work
- Top-10% rate
- 8.8% record average 16.5%
- Open access
- 34% world 28%
Not ranked overall: Chiesi Foundation is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 5.8×. Every wedge is a field page.
- Veterinary 5.8×
- Chemistry 4.6×
- Pharmacology, Toxicology and Pharmaceutics 4.5×
- Medicine 3.0×
- Biochemistry, Genetics and Molecular Biology 2.4×
- Immunology and Microbiology 2.3×
- Neuroscience 1.0×
- Economics, Econometrics and Finance 0.8×
- Health Professions 0.8×
- Dentistry 0.7×
- Nursing 0.6×
- Materials Science 0.5×
- Agricultural and Biological Sciences 0.4×
- Psychology 0.3×
- Engineering 0.2×
- Environmental Science 0.2×
- Physics and Astronomy 0.2×
- Social Sciences 0.1×
- Computer Science 0.1×
Who are the top researchers at Chiesi Foundation?
Ranked on the composite score, S Bongrani lead among researchers whose main affiliation is Chiesi Foundation.
- 1 S Bongrani Italy · #1,075,341 worldwide 22 citations · 16 works
Which keywords describe research at Chiesi Foundation?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Fibrosis, TGF-ß, Inflammation, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Inhaler Devices, Pulmonary Drug Delivery and Pulmonary Hypertension.
- CCN Family
- spirometry
- COPD
- Respiratory Distress Syndrome
- Diagnosis
- TGF-ß Signaling
- Right Heart Assessment
- Echocardiography
- Asthma
- Endothelial Dysfunction
- Epidemiology
- Pulmonary Hypertension
- Interstitial Lung Disease
- Idiopathic Pulmonary Fibrosis
- Inflammation
- Fibrosis
- TGF-ß
- Inhaler Devices
- Pulmonary Drug Delivery
- Treatment
- Genetics
- Allergic Diseases
- Treatment Guidelines
- Chronic Kidney Disease
- Preterm Infants
- Angiogenesis
- Management
- Bronchopulmonary Dysplasia
- Lung Stem Cells
- Cell Adhesion
- Connective Tissue Growth Factor
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 31 words, with their numbers
- Fibrosis5▲ 85×4 topics
- Inflammation4▲ 5.8×15 topics
- TGF-ß3▲ 70×2 topics
- Idiopathic Pulmonary Fibrosis3▲ 221×1 topic
- Inhaler Devices3▲ 406×1 topic
- Interstitial Lung Disease3▲ 161×1 topic
- Pulmonary Drug Delivery3▲ 406×1 topic
- Pulmonary Hypertension3▲ 68×3 topics
- Treatment3▲ 7.2×6 topics
- Epidemiology3▲ 2.1×7 topics
- Genetics2▲ 10×3 topics
- Endothelial Dysfunction2▲ 30×2 topics
- Allergic Diseases2▲ 107×1 topic
- Asthma2▲ 65×1 topic
- Treatment Guidelines2▲ 28×2 topics
- Echocardiography2▲ 21×2 topics
- Chronic Kidney Disease2▲ 22×1 topic
- Right Heart Assessment2▲ 133×1 topic
- Preterm Infants2▲ 42×3 topics
- TGF-ß Signaling2▲ 75×3 topics
- Angiogenesis1▲ 14×5 topics
- Diagnosis1▲ 4.6×4 topics
- Management1▲ 5.7×2 topics
- Respiratory Distress Syndrome1▲ 51×2 topics
- Bronchopulmonary Dysplasia1▲ 61×1 topic
- COPD1▲ 60×1 topic
- Lung Stem Cells1▲ 68×1 topic
- spirometry1▲ 60×1 topic
- Cell Adhesion1▲ 91×2 topics
- CCN Family1▲ 577×1 topic
- Connective Tissue Growth Factor1▲ 162×1 topic
Which research topics does Chiesi Foundation publish most on?
By volume in 2022–2025: Inhalation and Respiratory Drug Delivery, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Asthma and respiratory diseases and Pulmonary Hypertension Research and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 3 works
- 2 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 3 works
- 3 Asthma and respiratory diseases Physiology 2 works
- 4 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 2 works
- 5 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 1 works
- 6 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 1 works
- 7 Connective Tissue Growth Factor Research Molecular Biology 1 works
- 8 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 1 works
- 9 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works
- 10 Delphi Technique in Research Sociology and Political Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Chiesi Foundation's research output changed?
Output in 2018–2022 was 8% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Parma
- University of Parma
- Ospedale di Parma
- Consorzio Nazionale Interuniversitario per le Telecomunicazioni
- Institute of Materials for Electronics and Magnetism
- European Food Safety Authority
- Chiesi (Italy)
- Experimental Station for the Food Preserving Industry
- Azienda Unita' Sanitaria Locale di Parma
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.